Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD

OBJECTIVE: A genome-wide association study in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial identified two markers (rs57922 and rs9299870) that were significantly associated with cardiovascular mortality during intensive glycemic control and could potentially be used, when com...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Shah, Hetal S., Morieri, Mario Luca, Marcovina, Santica M., Sigal, Ronald J., Gerstein, Hertzel C., Wagner, Michael J., Motsinger-Reif, Alison A., Buse, John B., Kraft, Peter, Mychaleckyj, Josyf C., Doria, Alessandro
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2018
Matèries:
Cardiovascular and Metabolic Risk
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5780047/
https://ncbi.nlm.nih.gov/pubmed/29183908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc17-1638
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars